New York · Nonprofit
MEMORIAL SLOAN-KETTERING CANCER CENTER
MEMORIAL SLOAN-KETTERING CANCER CENTER (New York) receives grants from 44 organizations whose IRS filings report $41,612,236 to it, the largest being PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY ($24,713,194). 32 of them have funded it in more than one year.
- Revenue FY2024
- $8.5B
- Funders on record
- 44
- Grants received
- $42M
- Net assets
- $10.0B
What Memorial Sloan-Kettering Cancer Center does
Mission
Leadership in the prevention, treatment, and cure of cancer through excellence, vision and cost effectiveness in patient care, outreach programs, research, and education.
As stated on its FY2024 Form 990.
Programs
Patient care: Memorial Sloan-Kettering Cancer Center experts have established standards of care and treatment protocols for each type and stage of cancer. Our physicians have an extraordinary depth and breadth of experience in diagnosing and treating all forms of the disease, from the most common to the very rare. Each year, they treat more than 400 different subtypes of cancer. This level of specialization can have an often-dramatic effect on a patient's chances for a cure or control of their cancer. While we are known for our advanced, innovative therapies, our physicians are equally well regarded for their compassion and concern. Our disease management program features 16 multidisciplinary cancer teams. Patients are treated by as many different specialists as are needed for their particular type of disease, including surgeons, medical oncologists, radiation oncologists, radiologists, pathologists, psychiatrists, and nurses. Our pathologists have unsurpassed expertise in using advanced methods to accurately diagnose cancer. Because of their sole focus on cancer, our surgeons use surgical techniques that preserve form and function. Our radiation oncologists are developing and…
$5,863,755,670 spentof which $8,938,230 as grants$6,105,881,000 earned by the program83% of program spendingResearch: Memorial Sloan-Kettering Cancer Center maintains one of the world's most dynamic programs of cancer research. The extraordinary patient care we provide benefits from our innovative programs in basic, translational, and clinical research. Research at sloan-kettering institute is dedicated to understanding the biology of cancer through programs in cell biology, enetics, biochemistry, molecular biology, structural biology, computational biology, immunology, and therapeutics. Investigators at sloan-kettering institute collaborate with memorial hospital physician-scientists, a partnership that helps speed important research findings from the laboratory to the bedside, in a process known as translational research. Memorial Sloan-Kettering Cancer Center also actively initiates and participates in clinical trials to identify more effective cancer therapies, and our physicians are currently leading more than 1,900 clinical trials for pediatric and adult cancers. The human oncology and pathogenesis program (hopp) is a further effort to increase institutional research strength in areas important in contemporary translational research. Hopp is designed to meld even more thoroughly…
$975,731,057 spentof which $15,954,437 as grants$201,058,000 earned by the program14% of program spendingEducation: education is a vital part of Memorial Sloan-Kettering Cancer Center's mission. Our training programs prepare physicians and scientists for careers in the biomedical sciences. Our collaborations with the rockefeller university, cornell university, and weill medical college of cornell university offer phd programs in chemical biology, computational biology and medicine, and the medical sciences. The center also partners with weill medical college and the rockefeller university to offer a md/phd degree for aspiring physician-scientists. The center has a phd program in cancer biology through its louis v. Gerstner, jr. Graduate school of biomedical sciences. This novel program has been enrolling students since 2006 and trains basic laboratory scientists to work in research areas directly relevant to cancer and other human diseases. We also offer postgraduate clinical fellowships to train physicians who seek special expertise in a particular type of cancer and postgraduate research fellowships that provide physicians and scientists with advanced laboratory research training. With faculty appointments at the weill medical college of cornell university, our clinical staff also…
$240,313,367 spentof which $2,668,655 as grants3% of program spending
The 3 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $7,079,800,094.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $11.6B to $13.3B (+15%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 4% · 2018 4% · 2019 4% · 2020 4% · 2021 3% · 2022 3% · 2023 4% · 2024 4%. Grants only. Government contracts and fees sit inside program revenue.
10% of MEMORIAL SLOAN-KETTERING CANCER CENTER’s revenue is contributions — more reliant on donations than three-quarters of its peers (1% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Who funds it, year by year
2017 → 2023: the base narrowed from 19 funders to 16 funders, grant income fell $9.8M → $1.5M.
22 of 44 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 14% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $11M from 15 payers (the payer shares this organization's board, largest St Louis Community Foundation Inc). These are real filings, and they are not money MEMORIAL SLOAN-KETTERING CANCER CENTER raised.
From the IRS filings of MEMORIAL SLOAN-KETTERING CANCER CENTER’s funders (the co-funder graph). Top 30 of 44 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
MEMORIAL SLOAN-KETTERING CANCER CENTER leans on a few funders — its largest provides 59% of grant income and the top three 74%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
100% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund MEMORIAL SLOAN-KETTERING CANCER CENTER.
Largest funder’s share by year: 2017 59% · 2018 81% · 2019 66% · 2020 83% · 2021 48% · 2022 29% · 2023 18% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
37% of MEMORIAL SLOAN-KETTERING CANCER CENTER's funders are still giving 3 years after their first grant; 73% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
MEMORIAL SLOAN-KETTERING CANCER CENTER draws 78% of its grant income from funders outside New York, across 9 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $6.0M arriving through sponsors registered in 17 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
MEMORIAL SLOAN-KETTERING CANCER CENTER holds deeper cash reserves than three-quarters of the 2,075 health nonprofits its size.
this organization peer median middle 50% of peers· 2,075 health nonprofits over $100M, FY2024
Organizations like MEMORIAL SLOAN-KETTERING CANCER CENTER
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
99% of spending goes to programs.
Governance
Public support
79%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 50 states
Part of a family of 41 related entities
- Prostate Cancer Clinical Trials · disregarded
- Msk Abc LLC · disregarded
- Memorial Medical Care PC · exempt
- Tri-Institutional Therapeutics Disc Inst · exempt
- Mskcc Regional Network · partnership
Screen this organization
A dated, signed PDF of the compliance screen for MEMORIAL SLOAN-KETTERING CANCER CENTER: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds MEMORIAL SLOAN-KETTERING CANCER CENTER?
- MEMORIAL SLOAN-KETTERING CANCER CENTER (New York) receives grants from 44 organizations whose IRS filings report $41,612,236 to it, the largest being PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY ($24,713,194). 32 of them have funded it in more than one year.
- How many funders does MEMORIAL SLOAN-KETTERING CANCER CENTER have?
- IRS filings report 44 organizations giving $41,612,236 in grants to MEMORIAL SLOAN-KETTERING CANCER CENTER, 32 of which have funded it in more than one year.
- Who is the largest funder of MEMORIAL SLOAN-KETTERING CANCER CENTER?
- PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY is the largest funder on record, with $24,713,194 in grants. The full list of funders is on this page.
- How can an organization like MEMORIAL SLOAN-KETTERING CANCER CENTER find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 44 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing